title: Identification of appropriate patients for cardiometabolic risk management.
abstract: Patients at increased risk for cardiovascular disease have a wide array of clinical features that should alert practitioners to the need for risk reduction. Some, but not all, of these features relate to insulin resistance. Multiple approaches exist for diagnosing and defining this risk, including the traditional Framingham risk assessment, various definitions of the metabolic syndrome, and assessment of risk factors not commonly included in the standard criteria. This article reviews the many clinical findings that should alert healthcare providers to the need for aggressive cardiovascular risk reduction.
authors.affiliation: Division of Endocrinology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
authors.forename: Anne L
authors.initials: AL
authors.lastname: Peters
mesh_terms: D000367:Age Factors; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control*; D016640:Diabetes, Gestational / Q000175:diagnosis / Q000628:therapy; D050171:Dyslipidemias / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D005234:Fatty Liver / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D007333:Insulin Resistance; D008297:Male; D001523:Mental Disorders / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D024821:Metabolic Syndrome / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D009043:Motor Activity; D009765:Obesity / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D018579:Patient Selection; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D018570:Risk Assessment; D012307:Risk Factors